Poland, April 17 -- Poland based Takeda Pharma Sp. z o.o. has secured contract from Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie for Pharmaceutical products Delivery of medicinal products containing rADAMTS13 substances. The value of the contract is worth 28726450700 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....